CARDIOPULMONARY BYPASS AND CELLULAR-IMMUNITY - CHANGES IN LYMPHOCYTE SUBSETS AND NATURAL-KILLER-CELL ACTIVITY

被引:47
作者
TAJIMA, K
YAMAMOTO, F
KAWAZOE, K
NAKATANI, I
SAKAI, H
ABE, T
KAWASHIMA, Y
机构
[1] NATL CARDIOVASC CTR,DEPT CARDIOVASC SURG,5-7-1 FUJISHIRO DAI,SUITA,OSAKA 565,JAPAN
[2] NAGOYA UNIV,SCH MED,DEPT THORAC SURG,NAGOYA,AICHI 466,JAPAN
关键词
D O I
10.1016/0003-4975(93)90265-J
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To investigate whether cell-mediated immunity responses are suppressed or activated by the effect of cardiopulmonary bypass (CPB), we studied peripheral blood lymphocyte subsets and antibody-dependent cell-mediated cytotoxicity in 52 adult patients who had undergone open heart operations. Lymphocyte function also was studied with regard to mixed lymphocyte reaction, which indicates the amount of DNA synthesis of lymphocytes, and natural killer (NK) cytotoxicity, which represents the killing activity of NK cells on the tumor cells (K-562), in 11 patients. The total T lymphocyte (OKT3+ and OKT11+) number showed no significant change during CPB. Suppressor/cytotoxic T cell (OKT8+) and NK cell (Leu7+ and Leu11+) numbers were found to be remarkably increased. However, helper/inducer T cell (OKT4+) and B cell (Leu12+) numbers were decreased during CPB. Antibody-dependent cell-mediated cytotoxicity was elevated during CPB. All of these changes were almost returned to the preoperative levels by the seventh day after operation. Mixed lymphocyte reaction and NK cytotoxicity were also activated during CPB. The results show that heart operations in which cardiopulmonary bypass is used are associated with activation of cytotoxic cell-mediated immunity.
引用
收藏
页码:625 / 630
页数:6
相关论文
共 20 条
[1]   HEMATOLOGICAL ADVANTAGE OF A MEMBRANE-OXYGENATOR OVER A BUBBLE OXYGENATOR IN LONG PERFUSIONS [J].
BOONSTRA, PW ;
VERMEULEN, FEE ;
LEUSINK, JA ;
DENOOY, EH ;
VANZALK, A ;
SOONS, JBJ ;
WILDEVUUR, CRH .
ANNALS OF THORACIC SURGERY, 1986, 41 (03) :297-300
[2]   COMPLEMENT ACTIVATION DURING CARDIOPULMONARY BYPASS - EVIDENCE FOR GENERATION OF C3A AND C5A ANAPHYLATOXINS [J].
CHENOWETH, DE ;
COOPER, SW ;
HUGLI, TE ;
STEWART, RW ;
BLACKSTONE, EH ;
KIRKLIN, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (09) :497-503
[3]  
FOSSE E, 1987, J THORAC CARDIOV SUR, V93, P860
[4]  
GRANT JA, 1975, J IMMUNOL, V114, P1101
[5]  
HAEFFNERCAVAILLON N, 1989, J THORAC CARDIOV SUR, V98, P1100
[6]  
HISATOMI K, 1989, J THORAC CARDIOV SUR, V98, P580
[7]   THE EFFECT OF CARDIOPULMONARY BYPASS ON T-CELLS AND THEIR SUBPOPULATIONS [J].
IDE, H ;
KAKIUCHI, T ;
FURUTA, N ;
MATSUMOTO, H ;
SUDO, K ;
FURUSE, A ;
ASANO, K .
ANNALS OF THORACIC SURGERY, 1987, 44 (03) :277-282
[8]   CARDIOVASCULAR-DISEASE AND IMMUNOLOGY IN CARDIAC-SURGERY [J].
MANABE, H ;
SHIRAKURA, R ;
MORI, T .
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1975, 39 (04) :453-458
[9]  
NAVARRO M, 1989, J THORAC CARDIOVASC, V96, P962
[10]  
OMOKAWA S, 1986, T AM SOC ART INT ORG, V32, P392